US20190343533A1 - Intra-aneurysmal device - Google Patents
Intra-aneurysmal device Download PDFInfo
- Publication number
- US20190343533A1 US20190343533A1 US16/477,173 US201816477173A US2019343533A1 US 20190343533 A1 US20190343533 A1 US 20190343533A1 US 201816477173 A US201816477173 A US 201816477173A US 2019343533 A1 US2019343533 A1 US 2019343533A1
- Authority
- US
- United States
- Prior art keywords
- head
- stent
- intermediate portion
- aneurysm
- wires
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010002329 Aneurysm Diseases 0.000 claims abstract description 68
- 210000001367 artery Anatomy 0.000 claims abstract description 30
- 230000017531 blood circulation Effects 0.000 claims abstract description 21
- 238000011282 treatment Methods 0.000 claims abstract description 8
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 7
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 238000002788 crimping Methods 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000000560 biocompatible material Substances 0.000 claims description 2
- 230000008901 benefit Effects 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 238000012276 Endovascular treatment Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000008450 Intracranial aneurysm Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00477—Coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12063—Details concerning the detachment of the occluding device from the introduction device electrolytically detachable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
Definitions
- the invention relates to the field of intra-aneurysmal medical devices. More precisely, the invention relates to intra-aneurysmal devices with flow diversion.
- Aneurysm means a dilation of the wall of an artery.
- the dilation causes an aneurysmal sac that communicates with the artery through a narrowed zone known to practitioners as a “neck”.
- Aneurysms are caused by several factors. It should be noted that prevalence is higher in elderly persons. The risk of rupture in these persons is also higher, particularly due to related pathologies such as high blood pressure that result in an increase in arterial blood pressure.
- One of the techniques is called “endovascular” and includes a step to treat the aneurysm using an intra-aneurysmal device.
- An extra-aneurysmal or intra-aneurysmal device, or both, can also be used.
- the aneurysm is approached following the path of the arteries.
- a carrier catheter (carrying an intra-aneurysmal device) is introduced through the arteries and directed under radioscopic control.
- the device is then deposited in the aneurysm.
- the device is deposited in the artery carrying the aneurysm in the case of an extra-aneurysmal device or in the aneurysm in the case of an intra-aneurysmal device. This isolates the aneurysm from the blood flow of the artery so that the aneurysmal sac will not rupture under the effect of blood pressure.
- Intra-aneurysmal devices are known in the medical field.
- the international application published under number WO 2006/052322 describes an intra-aneurysmal device aimed at securing the implantation of “coils”.
- the term “coils” refers to a small turn of metal used to close off a vessel.
- Many intra-aneurysmal devices use coils to fill the aneurysmal sac of the aneurysm to be treated so as to limit the blood flow towards the aneurysm.
- these coils can form a danger because they can inadvertently be positioned in the source artery (consequently hindering the blood flow), and they can also move over time from the aneurysm to the source artery (also hindering blood circulation).
- the device comprises a stent that anchors the device in a source artery, carrying the aneurysm.
- the term stent is currently used in the medical field to denote a tube with an approximately circular section.
- Anchorage is made by endothelialisation of the stent on the internal wall of the artery.
- the device comprises a head, generally in the form of a dome that will be housed inside the aneurysmal sac.
- the device comprises a thinned intermediate portion between the dome and the stent, through which the blood flow passes.
- This device cannot treat all types of aneurysm.
- Some aneurysms are said to be “wide neck” aneurysms.
- a wide neck aneurysm is a difficult anatomical situation that corresponds to a particularly wide entry.
- the stability of endovascular treatments is often difficult with this type of aneurysm.
- the dome is not stable and can move inside the aneurysmal sac over time, or even worse can escape from it, which in the best of cases will render the device useless and in the worst case can cause complications for the patient.
- a wide neck does not provide the dome with the support area (or contact area) necessary for the dome to remain in the aneurysmal sac for a long period.
- this device cannot treat a wide neck aneurysm efficiently because it would not be stable and could be inefficient or even dangerous for the patient, particularly in the long term.
- Another disadvantage of this device is that it can require the use of coils. Consequently, it is necessary to use an additional tool to put the coils in position in the aneurysm once the device has been installed in the patient. This can extend the placement time and require more operations to be performed by the practitioner, to the detriment of the patient's safety.
- this device comprises an intermediate part with a thrombogenic nature.
- the wires that make the connection between the anchorage stent and the half-dome occupy a significant space at the centre of the artery carrying the aneurysm.
- This meshed structure then forms an ideal location for local endothelialisation and consequently a thrombosis in the carrier artery.
- a first object is to provide an intra-aneurysmal device that can be adapted to any type of aneurysm and particularly wide neck aneurysms.
- a second object is to provide an intra-aneurysmal device that does not require the addition of any supplementary equipment inside the aneurysm (coils).
- a third object is to provide an intra-aneurysmal device with good stability regardless of the form of the aneurysm.
- a fourth object is to provide a device that is stable when it is used to treat an aneurysm located in the vicinity of an arterial bifurcation.
- a fifth object is to provide a device with an anchorage that is more stable in the long term than existing devices.
- a sixth object is to provide an ergonomic device for the practitioner.
- an intra-aneurysmal device for the treatment of an aneurysm comprising:
- This device is easily adapted to any type of aneurysm.
- it can be used to treat wide neck aneurysms due to its ellipsoid shaped intermediate portion and its diameter being larger than the diameter of the stent.
- This geometry can also advantageously improve the stability of the intra-aneurysmal device regardless of the form of the aneurysm and particularly an aneurysm located in the vicinity of an arterial bifurcation.
- the intermediate portion with the stent can make an anchorage stable in the long term.
- FIG. 1 is a two-dimensional view of a treatment device according to the invention
- FIG. 2 is a two-dimensional view of the device in FIG. 1 , when the device is installed in an aneurysm in the vicinity of an arterial bifurcation;
- FIG. 3 is a sectional view of a first ring
- FIG. 4 comprises several perspective views of the device according to one variant embodiment.
- FIG. 5 is a sectional view of a second ring:
- FIGS. 6 a , 6 b , 6 c and 6 d represent a first method of fabricating the device
- FIGS. 7 a , 7 b , and 7 c represent a second method of fabricating the device
- FIG. 8 is a perspective view of the device according to one variant embodiment.
- a wide neck aneurysm is an aneurysm for which the aneurysm height to neck width ratio is greater than 1.5.
- the aneurysm height is the distance H that separates a point P 1 located at the vertex of the aneurysm and a point P 2 at the entry to the aneurysm.
- the neck width is the distance L that separates the lateral edges at the entry to the aneurysm.
- FIG. 1 shows an intra-aneurysmal device 1 .
- the intra-aneurysmal device 1 is designed for the treatment of an aneurysm 2 .
- This device 1 is designed for an endovascular treatment. It can be used for any type of wide neck or other aneurysm 2 .
- This device 1 can also be used to treat aneurysms 2 regardless of which part of the body is affected.
- the device 1 comprises a stent 3 , an intermediate portion 4 and a head 5 in the form of a dome.
- the intermediate portion 4 is located between the stent 3 and the head 5 .
- the stent 3 , the intermediate portion 4 and the head 5 are advantageously fabricated using at least one wire.
- the stent 3 , the intermediate portion 4 and the head 5 are advantageously fabricated using a plurality of wires 6 , preferably made of nitinol.
- Nitinol has interesting mechanical properties, namely shape memory and its elasticity. Furthermore, nitinol is biocompatible and has a super-elastic mechanical behaviour.
- At least one wire is radio-opaque. This makes it possible to display the wire on a screen during the operation, so that the open state of the device 1 can also be observed.
- the wires 6 are arranged relative to each other so as to form a mesh.
- the stent 3 is in the form of a meshed flexible tube.
- the section of the stent 3 is advantageously approximately circular. However, it should be noted that the characteristics of the stent 3 are such that the stent is flexible. Thus, the shape of the section can vary depending on whether or not a force is applied around the stent 3 . The stent can thus adapt to the shape of the artery.
- the section of the stent 3 is consequently advantageously circular and has a diameter D 1 .
- the intermediate portion 4 extends from an upper end 7 of the stent 3 .
- the mesh of the intermediate portion 4 is advantageously identical to the mesh of the stent 3 .
- the number of wires in the intermediate portion 4 is advantageously identical to the number in the stent 3 .
- the stent 3 and the intermediate portion 4 may each be formed from four to thirty-two nitinol wires 6 depending on the size of the implant.
- the number of wires 6 can vary depending on the size of the implant. This number of wires makes it possible to obtain a large mesh to avoid blocking the blood flow in the source artery, and blood can also flow freely through the intermediate portion 4 and through the stent 3 . Consequently, the risk of formation of blood clot caused by a foreign body (the device 1 ) is reduced.
- the head 5 extends from the intermediate portion 4 . It is in the form of a concave dome, in which the concave part 9 a faces outwards. Once the device 1 has been installed on a patient, the concave part 9 a faces the aneurysmal sac 8 as illustrated in FIG. 2 .
- the mesh of the head 5 is made of wires 6 , preferably nitinol wires. Nevertheless, unlike the stent 3 and the intermediate portion 4 , a larger number of wires 6 is used. Alternatively, finer braiding can be made. Between thirty-two and two hundred wires are used in the mesh of the head 5 .
- the mesh in the head 5 is a fine mesh, finer than the mesh of the stent 3 and the intermediate portion 4 , which can considerably reduce the blood flow to the aneurysmal sac 8 without completely sealing it and isolating it from the artery. In this way, blood circulation in the aneurysmal sac 8 reduces and blood progressively stagnates in said aneurysmal sac 8 to induce a fast thrombosis. This advantageously helps to avoid the use of coils.
- the head 5 comprises between four and thirty-two wires, like the stent and the intermediate portion.
- the wires of the head form an angle with a longitudinal axis 19 of the device 1 equal to less than the angle formed by the wires of the stent and the intermediate portion.
- the wires of the stent and the intermediate portion form an angle with the longitudinal axis 19 equal to about 50° and the wires of the head form an angle with the longitudinal axis 19 equal to about 140°. This can advantageously result in the same number of wires regardless of the portion of the device, while assuring that the head performs the function of diverting the blood flow.
- the head 5 is locally concave 9 around a centre 10 of the dome, the concave part 9 facing the intermediate portion 4 .
- This concave part 9 is particularly useful in that the head 5 has a rounded shape facing the inside of the aneurysmal sac 8 such that it does not extend or extends only slightly in an artery. Due to its characteristics (fine mesh), the head 5 can hinder blood flow in the artery.
- the concave part 9 located around the centre 10 of the head 5 means that the head does not hinder blood circulation in the artery, thus reducing intra-luminal curvature.
- the objective is to limit or avoid the presence of the head 5 in the artery to avoid reducing the section of the artery.
- a head 5 that extends in the artery could cause fast aggregation of platelets, and potentially the formation of blood clot in the source artery or in the arterial bifurcation.
- the intermediate portion 4 is in the form of an ellipsoid.
- the expression “ellipsoid” is not identical to the universally known mathematical definition.
- the term “ellipsoid” denotes an ellipsoid shape in three dimensions.
- An ellipse as defined mathematically has a closed contour.
- the intermediate portion 4 even though it visually resembles an ellipsoidal shape, does not have a closed contour, particularly in the vicinity of a proximal end 12 .
- the intermediate portion 4 In the vicinity of its proximal end 12 , the intermediate portion 4 is open on the stent 3 such that the internal volume defined by the intermediate portion communicates with the internal volume defined by the stent 3 .
- the intermediate portion 4 is continuous with the stent 3 and prolongs it.
- the intermediate portion 4 and the stent 3 are connected by a node.
- a node is a zone of the device in which the wires are braided, pinched or held in place by a ring so as to significantly reduce the diameter of the device at this location.
- a distal end 11 of the intermediate portion 4 is connected to the head 5 using a node 14 in the vicinity of a junction 13 between said head 5 and said intermediate portion 4 .
- the connection between the intermediate portion 4 and the head 5 will be called “nodal link”.
- the nodal link advantageously enables the head 5 to move freely relative to the intermediate portion 4 and globally relative to the remainder of the stent 3 .
- This enables the device 1 to adapt to all anatomies because the head 5 can thus be on an axis different from a longitudinal axis 19 of the device 1 .
- An aneurysm 2 that is not on the axis of an artery through which the device 1 passes can consequently be treated due to mobility of the head 5 that is made possible as a result of the nodal link described above.
- the intermediate portion 4 has an ellipsoid shape that approaches a spheroid. Note that a sphere is a special case of an ellipsoid.
- the intermediate portion 4 that is ellipsoidal in shape, jointly with the stent 3 , advantageously solves this stability problem.
- the shape of an external wall 15 of the head 5 facing the intermediate portion 4 is approximately the corresponding shape to an upper wall 16 of said intermediate portion 4 .
- This enables a harmonious contact between the head 5 and the intermediate portion 4 , if there should be any contact between these two elements.
- the term “harmonious” indicates that the shape of the external wall 15 is such that the head 5 can rest on the intermediate portion 4 , that can thus possibly act as a support for the head 5 .
- the device 1 is inserted in a wide neck aneurysm 2 . More precisely, the head 5 is inserted inside the aneurysmal sac 8 . When the head 5 is extended, its walls bear on the walls of the aneurysmal sac 8 that confers its initial stability conditions on the device 1 . Long term stability of the device 1 is achieved as described later.
- the intermediate portion 4 is located at a bifurcation between a main artery A and two secondary arteries B.
- the intermediate portion 4 bears on the walls of the artery A.
- the intermediate portion 4 bears on two support points 17 .
- the stent 3 the intermediate portion 4 will be subjected to the endothelialisation phenomenon that can fix it onto the wall of the arteries.
- the intermediate portion 4 and the stent 3 thus jointly provide better long-term stability than existing devices.
- a transverse diameter 18 of the intermediate portion 4 is larger than a diameter D 1 of the stent 3 .
- the transverse diameter 18 of the intermediate portion 4 aims at the width of the intermediate portion along a direction transverse to a longitudinal axis 19 of the device 1 , in other words approximately perpendicular to said longitudinal axis 19 . This gives better stability for the intermediate portion 4 .
- the head 5 is dome-shaped in which the largest diameter 20 is generally between 4 and 13 mm.
- the diameter D 1 of the stent 3 may for example be between 2.5 and 4 mm and its length 21 may be between 15 and 25 mm.
- the intermediate portion 4 comprises a transverse diameter 18 equal to about 4-5 mm.
- these values are variable and depend mainly on the location of the aneurysm to be treated. An aneurysm located in the brain does not have the same dimensions as an aneurysm located in another part of the body.
- the device 1 comprises an electrolytic detachment system that detaches the device 1 once it has been put into place in the aneurysm.
- the detachment system is located at one end 22 of the stent 3 .
- the device 1 comprises an annular ring 30 that can be seen in section in FIG. 3 and in perspective in FIG. 4 .
- the annular ring 30 is located on the stent.
- the annular ring 30 is located at one end of the stent 3 .
- the annular ring 30 is fabricated from a radio-opaque material, for example such as titanium or platinum.
- the annular ring 30 brings together all the wires forming the device so as to contain all said wires if necessary, for example so as to reposition the device 1 .
- the ring 30 is in the form of an annular body comprising a rounded edge 32 .
- the rounded edge is located in the vicinity of the end of the stent 3 .
- the rounded edge 32 facilitates retraction of the device by means of a cylindrical shaped catheter 33 .
- edges of the catheter stop on the rounded edge 32 of the annular ring 30 , that enters the catheter progressively. This makes it easier to retract the device 1 to reposition it, to replace it or to remove it, provided that the endothelialisation phenomenon does not prevent it.
- an outside diameter D 2 of the annular ring 30 is between 150 and 250 ⁇ m and is preferably about 200 ⁇ m. This value advantageously facilitates handling of the device 1 in a 0.5 mm diameter catheter. In any case, the ring diameter is less than the diameter of the handling catheter.
- the device 1 comprises a second annular ring 31 identical to the ring 30 .
- the second ring 31 is located between the head 5 and the intermediate portion 4 .
- the second annular ring 31 acts firstly as a marker to help the surgeon position the device in the aneurysm and secondly enables better attachment close to the node.
- the surgeon can use it to position the device precisely in that the second annular ring is positioned in the vicinity of the neck of the aneurysm.
- the second annular ring 31 is superposed on the node, while keeping head 5 perfectly mobile relative to the intermediate portion 4 .
- the second ring 31 is used to position the head in the aneurysm precisely, this ring being easily identified by the practitioner.
- the second ring 31 informs the practitioner of the boundary between the head 5 and the intermediate portion 4 .
- the rings 30 , 31 are fixed to said device, so that the rings cannot move relative to the device 1 .
- the rings 30 , 31 are fixed on the device 1 by crimping. Crimping is a mechanical process involving plastic deformation to fix it on the device 1 .
- a first advantage of this device is that it can be adapted to any type of aneurysm and particularly aneurysms with a wide neck.
- a second advantage is that it can be used to treat aneurysms without the addition of supplementary equipment (coils).
- a third advantage is that the device is stable regardless of the shape of the aneurysm and more particularly when the aneurysm neck is wide.
- a fourth advantage is that the device is also particularly stable when it is used to treat an aneurysm located close to an arterial bifurcation.
- a fifth advantage of the device is its stable anchorage that remains efficient in the long term.
- a sixth advantage is that the device is ergonomic for the practitioner.
- the device is designed to be delivered by a micro-catheter with a small outside diameter giving easier access to the most distant aneurysms without the addition of any supplementary material. Placement time is thus shortened.
- radio-opaque markers wires and/or rings
- the method includes a first step 61 in which a first stent 65 with a first mesh size is inserted partly in a second stent 66 with a second mesh finer than the first mesh, so as to form a portion 67 with a large mesh with the same mesh size as the first stent 65 and a portion 68 with a fine mesh, the mesh size of which is the superposition of the first and the second stent 65 , 66 .
- a node 14 is formed in the portion 68 with a fine mesh.
- the node 14 is positioned such that there is a fine zone 69 , 70 on each side of the node.
- the node 14 is a separation between the intermediate portion 4 and the head 5 .
- the second stent 68 that is located on the intermediate portion 4 and that with the first stent 67 forms the fine zone 69 , is retracted along the direction of the arrows A′′ towards the head 5 so as not to leave anything in the intermediate portion 4 other than the first stent 65 .
- the mesh of the intermediate portion is the same as the mesh of the first stent 65 .
- the mesh of the head 5 comprises three layers, namely a first layer of the first stent 65 , a second layer of the second stent 66 and a third layer of the second stent 66 that corresponds to the retracted portion in the third step 63 .
- a forming rod B′′ comprising an ellipsoid shaped end to form the intermediate portion 4 is inserted in the first stent 65 until it stops on node 14 and a forming element C for which the curve is a corresponding impression of a dome and is inserted in the second stent 68 stopping in contact on node 14 . All these elements are inserted in a mould D for which the moulding cavity defines a tubular portion and an ellipsoid portion and a dome-shaped portion.
- the mould is heated so as to heat seal the final device.
- the device comprises a first step in which a first rod B′ comprising an ellipsoid-shaped end is inserted in a stent 74 .
- the stent 74 comprises a large mesh part 75 and a small mesh part 75 .
- the first rod B′ is inserted until the end is adjacent to the small mesh portion 75 .
- a dome-shaped forming element is inserted in the fine mesh part 75 of the stent.
- the stent 74 and the elements A′, C′ are inserted in a mould D′.
- the assembly is then heated in the mould D′ to heat seal the final device.
- the node 14 is fabricated in mould D′ by heat sealing and due to the particular shape of the mould that enables local narrowing of the diameter of the device.
- the dome may have a complex geometry, to optimise diversion of the blood flow
- FIG. 8 illustrates a geometry of the dome capable of interrupting the blood flow.
- the density of the mesh of the head in the form of a flower is advantageously capable of efficiently diverting the blood flow.
- the flower shape is obtained by retracting the portion 69 several times inside the head 5 .
- the moulds used for the first and second methods can be in the form of a handle of variable section in which several devices can be fabricated simultaneously.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Pathology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Prostheses (AREA)
Abstract
-
- a stent (3) with an approximately circular section with diameter (D1), the stent (3) being suitable for and designed to anchor the device (1) in an artery,
- a head (5) designed to be inserted in the aneurysm (2), the head (5) being capable of significantly reducing blood flow in the aneurysm (2),
- an intermediate portion (4) located between the head (5) and the stent (3), and connecting the head (5) to the stent (3),
- wherein the intermediate portion (4) is in the form of an ellipsoid, of which a distal end (11) is connected to the head (5) and a proximal end (12) is connected to the stent (3).
Description
- The invention relates to the field of intra-aneurysmal medical devices. More precisely, the invention relates to intra-aneurysmal devices with flow diversion.
- “Aneurysm” means a dilation of the wall of an artery. The dilation causes an aneurysmal sac that communicates with the artery through a narrowed zone known to practitioners as a “neck”.
- Rupture of an aneurysm, or more precisely the aneurysmal sac, can have serious consequences, up to death. Aneurysms are caused by several factors. It should be noted that prevalence is higher in elderly persons. The risk of rupture in these persons is also higher, particularly due to related pathologies such as high blood pressure that result in an increase in arterial blood pressure.
- Consequently, it is a public health problem that needs to be treated. There are several treatment techniques.
- One of the techniques is called “endovascular” and includes a step to treat the aneurysm using an intra-aneurysmal device. An extra-aneurysmal or intra-aneurysmal device, or both, can also be used. In this case, the aneurysm is approached following the path of the arteries. A carrier catheter (carrying an intra-aneurysmal device) is introduced through the arteries and directed under radioscopic control. The device is then deposited in the aneurysm. In particular, the device is deposited in the artery carrying the aneurysm in the case of an extra-aneurysmal device or in the aneurysm in the case of an intra-aneurysmal device. This isolates the aneurysm from the blood flow of the artery so that the aneurysmal sac will not rupture under the effect of blood pressure.
- Intra-aneurysmal devices are known in the medical field. The international application published under number WO 2006/052322 describes an intra-aneurysmal device aimed at securing the implantation of “coils”. The term “coils” refers to a small turn of metal used to close off a vessel. Many intra-aneurysmal devices use coils to fill the aneurysmal sac of the aneurysm to be treated so as to limit the blood flow towards the aneurysm. However, these coils can form a danger because they can inadvertently be positioned in the source artery (consequently hindering the blood flow), and they can also move over time from the aneurysm to the source artery (also hindering blood circulation). Despite the fact that this document WO 2006/052322 discloses a device aimed at securing the insertion of coils, this device has many disadvantages, particularly due to the use of coils, both for patients and for practitioners. The use of coils is an inherently difficult treatment for the practitioner.
- In this document, the device comprises a stent that anchors the device in a source artery, carrying the aneurysm. The term stent is currently used in the medical field to denote a tube with an approximately circular section. Anchorage is made by endothelialisation of the stent on the internal wall of the artery. The device comprises a head, generally in the form of a dome that will be housed inside the aneurysmal sac. The device comprises a thinned intermediate portion between the dome and the stent, through which the blood flow passes.
- One disadvantage is that this device cannot treat all types of aneurysm. Some aneurysms are said to be “wide neck” aneurysms. A wide neck aneurysm is a difficult anatomical situation that corresponds to a particularly wide entry. The stability of endovascular treatments is often difficult with this type of aneurysm. The dome is not stable and can move inside the aneurysmal sac over time, or even worse can escape from it, which in the best of cases will render the device useless and in the worst case can cause complications for the patient. A wide neck does not provide the dome with the support area (or contact area) necessary for the dome to remain in the aneurysmal sac for a long period. Thus, this device cannot treat a wide neck aneurysm efficiently because it would not be stable and could be inefficient or even dangerous for the patient, particularly in the long term.
- Another disadvantage of this device is that it can require the use of coils. Consequently, it is necessary to use an additional tool to put the coils in position in the aneurysm once the device has been installed in the patient. This can extend the placement time and require more operations to be performed by the practitioner, to the detriment of the patient's safety.
- Another disadvantage is that this device has long term weaknesses for all types of aneurysms. Its architecture is such that it cannot provide a long term anchorage.
- Furthermore, this device comprises an intermediate part with a thrombogenic nature. The wires that make the connection between the anchorage stent and the half-dome occupy a significant space at the centre of the artery carrying the aneurysm. This meshed structure then forms an ideal location for local endothelialisation and consequently a thrombosis in the carrier artery.
- A first object is to provide an intra-aneurysmal device that can be adapted to any type of aneurysm and particularly wide neck aneurysms.
- A second object is to provide an intra-aneurysmal device that does not require the addition of any supplementary equipment inside the aneurysm (coils).
- A third object is to provide an intra-aneurysmal device with good stability regardless of the form of the aneurysm.
- A fourth object is to provide a device that is stable when it is used to treat an aneurysm located in the vicinity of an arterial bifurcation.
- A fifth object is to provide a device with an anchorage that is more stable in the long term than existing devices.
- A sixth object is to provide an ergonomic device for the practitioner.
- For this purpose, in the first place there is proposed an intra-aneurysmal device for the treatment of an aneurysm, this device comprising:
-
- a stent with an approximately circular section, the diameter being such that the stent is suitable for and designed to anchor the device in an artery,
- a head designed to be inserted in the aneurysm, the head being capable of significantly reducing blood flow in the aneurysm,
- an intermediate portion located between the head and the stent, and connecting the head to the stent, in which the intermediate portion is in the form of an ellipsoid, of which the distal end is connected to the head and a proximal end is connected to the stent, and in which a transverse diameter of the intermediate portion is larger or much larger than the diameter of the stent, the transverse diameter being approximately perpendicular to a longitudinal axis of the device and in which the intermediate portion and the head are connected by a node such that the head is free to move relative to the intermediate portion.
- This device is easily adapted to any type of aneurysm. In particular, it can be used to treat wide neck aneurysms due to its ellipsoid shaped intermediate portion and its diameter being larger than the diameter of the stent. This geometry can also advantageously improve the stability of the intra-aneurysmal device regardless of the form of the aneurysm and particularly an aneurysm located in the vicinity of an arterial bifurcation. Furthermore, the intermediate portion with the stent can make an anchorage stable in the long term.
- Various other characteristics can be included alone or in combination:
-
- the head is in the form of a dome;
- the head is concave around its centre, the concave part facing the intermediate portion;
- the intermediate portion continuously prolongs the stent;
- the head is composed of at least one wire forming an appropriate mesh and is designed to divert a large proportion of the blood flow;
- the head comprises between eight and two hundred wires and preferably between thirty-two and two hundred wires;
- the stent and/or the intermediate portion are made using at least one wire forming a mesh that enables blood flow through the stent and the intermediate portion;
- the shape of an external wall of the head facing the intermediate portion is approximately the corresponding shape to an upper wall of the intermediate portion;
- the wires are made of a biocompatible material, preferably nitinol, platinum or titanium
- at least one wire is radio-opaque;
- the device comprises an annular ring located on one end of the stent;
- the device comprises a second flexible annular ring located between the head and the intermediate portion;
- the annular ring and the second annular ring are fabricated from a radio-opaque material;
- the rings are fixed by crimping.
- Other special features and advantages of the invention will become clear from the description given below with reference to the appended drawings, given as non-limitative examples and in which:
-
FIG. 1 is a two-dimensional view of a treatment device according to the invention; -
FIG. 2 is a two-dimensional view of the device inFIG. 1 , when the device is installed in an aneurysm in the vicinity of an arterial bifurcation; -
FIG. 3 is a sectional view of a first ring; -
FIG. 4 comprises several perspective views of the device according to one variant embodiment. -
FIG. 5 is a sectional view of a second ring: -
FIGS. 6a, 6b, 6c and 6d represent a first method of fabricating the device; -
FIGS. 7a, 7b, and 7c represent a second method of fabricating the device; -
FIG. 8 is a perspective view of the device according to one variant embodiment. - In the following, a wide neck aneurysm is an aneurysm for which the aneurysm height to neck width ratio is greater than 1.5. The aneurysm height is the distance H that separates a point P1 located at the vertex of the aneurysm and a point P2 at the entry to the aneurysm. The neck width is the distance L that separates the lateral edges at the entry to the aneurysm.
-
FIG. 1 shows anintra-aneurysmal device 1. Theintra-aneurysmal device 1 is designed for the treatment of ananeurysm 2. Thisdevice 1 is designed for an endovascular treatment. It can be used for any type of wide neck orother aneurysm 2. Thisdevice 1 can also be used to treataneurysms 2 regardless of which part of the body is affected. - In the embodiment shown in
FIG. 1 , thedevice 1 comprises astent 3, anintermediate portion 4 and ahead 5 in the form of a dome. Theintermediate portion 4 is located between thestent 3 and thehead 5. - The
stent 3, theintermediate portion 4 and thehead 5 are advantageously fabricated using at least one wire. - The
stent 3, theintermediate portion 4 and thehead 5 are advantageously fabricated using a plurality ofwires 6, preferably made of nitinol. Nitinol has interesting mechanical properties, namely shape memory and its elasticity. Furthermore, nitinol is biocompatible and has a super-elastic mechanical behaviour. - Advantageously, at least one wire is radio-opaque. This makes it possible to display the wire on a screen during the operation, so that the open state of the
device 1 can also be observed. - The
wires 6 are arranged relative to each other so as to form a mesh. Thestent 3 is in the form of a meshed flexible tube. - The section of the
stent 3 is advantageously approximately circular. However, it should be noted that the characteristics of thestent 3 are such that the stent is flexible. Thus, the shape of the section can vary depending on whether or not a force is applied around thestent 3. The stent can thus adapt to the shape of the artery. - At rest, in other words, when no pressure is applied around the
device 1, the section of thestent 3 is consequently advantageously circular and has a diameter D1. - The
intermediate portion 4 extends from anupper end 7 of thestent 3. The mesh of theintermediate portion 4 is advantageously identical to the mesh of thestent 3. The number of wires in theintermediate portion 4 is advantageously identical to the number in thestent 3. For example, thestent 3 and theintermediate portion 4 may each be formed from four to thirty-twonitinol wires 6 depending on the size of the implant. The number ofwires 6 can vary depending on the size of the implant. This number of wires makes it possible to obtain a large mesh to avoid blocking the blood flow in the source artery, and blood can also flow freely through theintermediate portion 4 and through thestent 3. Consequently, the risk of formation of blood clot caused by a foreign body (the device 1) is reduced. - The
head 5 extends from theintermediate portion 4. It is in the form of a concave dome, in which theconcave part 9 a faces outwards. Once thedevice 1 has been installed on a patient, theconcave part 9 a faces theaneurysmal sac 8 as illustrated inFIG. 2 . - Like the
stent 3 and theintermediate portion 4, the mesh of thehead 5 is made ofwires 6, preferably nitinol wires. Nevertheless, unlike thestent 3 and theintermediate portion 4, a larger number ofwires 6 is used. Alternatively, finer braiding can be made. Between thirty-two and two hundred wires are used in the mesh of thehead 5. Thus, the mesh in thehead 5 is a fine mesh, finer than the mesh of thestent 3 and theintermediate portion 4, which can considerably reduce the blood flow to theaneurysmal sac 8 without completely sealing it and isolating it from the artery. In this way, blood circulation in theaneurysmal sac 8 reduces and blood progressively stagnates in saidaneurysmal sac 8 to induce a fast thrombosis. This advantageously helps to avoid the use of coils. - In one embodiment, the
head 5 comprises between four and thirty-two wires, like the stent and the intermediate portion. In this embodiment, the wires of the head form an angle with alongitudinal axis 19 of thedevice 1 equal to less than the angle formed by the wires of the stent and the intermediate portion. For example, the wires of the stent and the intermediate portion form an angle with thelongitudinal axis 19 equal to about 50° and the wires of the head form an angle with thelongitudinal axis 19 equal to about 140°. This can advantageously result in the same number of wires regardless of the portion of the device, while assuring that the head performs the function of diverting the blood flow. - The
head 5 is locally concave 9 around acentre 10 of the dome, theconcave part 9 facing theintermediate portion 4. Thisconcave part 9 is particularly useful in that thehead 5 has a rounded shape facing the inside of theaneurysmal sac 8 such that it does not extend or extends only slightly in an artery. Due to its characteristics (fine mesh), thehead 5 can hinder blood flow in the artery. Theconcave part 9 located around thecentre 10 of thehead 5 means that the head does not hinder blood circulation in the artery, thus reducing intra-luminal curvature. In other words, the objective is to limit or avoid the presence of thehead 5 in the artery to avoid reducing the section of the artery. Ahead 5 that extends in the artery could cause fast aggregation of platelets, and potentially the formation of blood clot in the source artery or in the arterial bifurcation. - The
intermediate portion 4 is in the form of an ellipsoid. In this application, the expression “ellipsoid” is not identical to the universally known mathematical definition. The term “ellipsoid” denotes an ellipsoid shape in three dimensions. An ellipse as defined mathematically has a closed contour. Nevertheless, theintermediate portion 4, even though it visually resembles an ellipsoidal shape, does not have a closed contour, particularly in the vicinity of aproximal end 12. In the vicinity of itsproximal end 12, theintermediate portion 4 is open on thestent 3 such that the internal volume defined by the intermediate portion communicates with the internal volume defined by thestent 3. In other words, theintermediate portion 4 is continuous with thestent 3 and prolongs it. - In one variant embodiment not shown on the figures, the
intermediate portion 4 and thestent 3 are connected by a node. - A node is a zone of the device in which the wires are braided, pinched or held in place by a ring so as to significantly reduce the diameter of the device at this location.
- A distal end 11 of the
intermediate portion 4 is connected to thehead 5 using anode 14 in the vicinity of ajunction 13 between saidhead 5 and saidintermediate portion 4. In the following, the connection between theintermediate portion 4 and thehead 5 will be called “nodal link”. - The nodal link advantageously enables the
head 5 to move freely relative to theintermediate portion 4 and globally relative to the remainder of thestent 3. This enables thedevice 1 to adapt to all anatomies because thehead 5 can thus be on an axis different from alongitudinal axis 19 of thedevice 1. Ananeurysm 2 that is not on the axis of an artery through which thedevice 1 passes can consequently be treated due to mobility of thehead 5 that is made possible as a result of the nodal link described above. - In one preferred embodiment represented on the figures, the
intermediate portion 4 has an ellipsoid shape that approaches a spheroid. Note that a sphere is a special case of an ellipsoid. - As explained above, in the case of a
wide neck aneurysm 2, there is no support zone to correctly stabilise thehead 5 in theaneurysmal sac 8. Theintermediate portion 4 that is ellipsoidal in shape, jointly with thestent 3, advantageously solves this stability problem. - Advantageously, the shape of an
external wall 15 of thehead 5 facing theintermediate portion 4 is approximately the corresponding shape to anupper wall 16 of saidintermediate portion 4. This enables a harmonious contact between thehead 5 and theintermediate portion 4, if there should be any contact between these two elements. The term “harmonious” indicates that the shape of theexternal wall 15 is such that thehead 5 can rest on theintermediate portion 4, that can thus possibly act as a support for thehead 5. - With reference to
FIG. 2 , thedevice 1 is inserted in awide neck aneurysm 2. More precisely, thehead 5 is inserted inside theaneurysmal sac 8. When thehead 5 is extended, its walls bear on the walls of theaneurysmal sac 8 that confers its initial stability conditions on thedevice 1. Long term stability of thedevice 1 is achieved as described later. - As can be seen in
FIG. 2 , theintermediate portion 4 is located at a bifurcation between a main artery A and two secondary arteries B. Theintermediate portion 4 bears on the walls of the artery A. For example, theintermediate portion 4 bears on two support points 17. As for thestent 3, theintermediate portion 4 will be subjected to the endothelialisation phenomenon that can fix it onto the wall of the arteries. Theintermediate portion 4 and thestent 3 thus jointly provide better long-term stability than existing devices. - Advantageously, a
transverse diameter 18 of theintermediate portion 4 is larger than a diameter D1 of thestent 3. Thetransverse diameter 18 of theintermediate portion 4 aims at the width of the intermediate portion along a direction transverse to alongitudinal axis 19 of thedevice 1, in other words approximately perpendicular to saidlongitudinal axis 19. This gives better stability for theintermediate portion 4. - In one embodiment suitable for the treatment of a cerebral aneurysm, the
head 5 is dome-shaped in which thelargest diameter 20 is generally between 4 and 13 mm. The diameter D1 of thestent 3 may for example be between 2.5 and 4 mm and itslength 21 may be between 15 and 25 mm. Theintermediate portion 4 comprises atransverse diameter 18 equal to about 4-5 mm. However, these values are variable and depend mainly on the location of the aneurysm to be treated. An aneurysm located in the brain does not have the same dimensions as an aneurysm located in another part of the body. - The
device 1 comprises an electrolytic detachment system that detaches thedevice 1 once it has been put into place in the aneurysm. In the embodiment represented on the figures, the detachment system is located at oneend 22 of thestent 3. - The
device 1 comprises anannular ring 30 that can be seen in section inFIG. 3 and in perspective inFIG. 4 . Theannular ring 30 is located on the stent. In particular, theannular ring 30 is located at one end of thestent 3. Theannular ring 30 is fabricated from a radio-opaque material, for example such as titanium or platinum. Theannular ring 30 brings together all the wires forming the device so as to contain all said wires if necessary, for example so as to reposition thedevice 1. - The
ring 30 is in the form of an annular body comprising arounded edge 32. The rounded edge is located in the vicinity of the end of thestent 3. Therounded edge 32 facilitates retraction of the device by means of a cylindrical shapedcatheter 33. In order to retract thedevice 1, edges of the catheter stop on therounded edge 32 of theannular ring 30, that enters the catheter progressively. This makes it easier to retract thedevice 1 to reposition it, to replace it or to remove it, provided that the endothelialisation phenomenon does not prevent it. - Advantageously, an outside diameter D2 of the
annular ring 30 is between 150 and 250 μm and is preferably about 200 μm. This value advantageously facilitates handling of thedevice 1 in a 0.5 mm diameter catheter. In any case, the ring diameter is less than the diameter of the handling catheter. - In one variant embodiment, the
device 1 comprises a secondannular ring 31 identical to thering 30. Thesecond ring 31 is located between thehead 5 and theintermediate portion 4. The secondannular ring 31 acts firstly as a marker to help the surgeon position the device in the aneurysm and secondly enables better attachment close to the node. As a marker, the surgeon can use it to position the device precisely in that the second annular ring is positioned in the vicinity of the neck of the aneurysm. The secondannular ring 31 is superposed on the node, while keepinghead 5 perfectly mobile relative to theintermediate portion 4. - The
second ring 31 is used to position the head in the aneurysm precisely, this ring being easily identified by the practitioner. Thesecond ring 31 informs the practitioner of the boundary between thehead 5 and theintermediate portion 4. - The
rings device 1. Therings device 1 by crimping. Crimping is a mechanical process involving plastic deformation to fix it on thedevice 1. - The
device 1 described above has several advantages. Thus, a first advantage of this device is that it can be adapted to any type of aneurysm and particularly aneurysms with a wide neck. A second advantage is that it can be used to treat aneurysms without the addition of supplementary equipment (coils). A third advantage is that the device is stable regardless of the shape of the aneurysm and more particularly when the aneurysm neck is wide. A fourth advantage is that the device is also particularly stable when it is used to treat an aneurysm located close to an arterial bifurcation. A fifth advantage of the device is its stable anchorage that remains efficient in the long term. A sixth advantage is that the device is ergonomic for the practitioner. In particular, the device is designed to be delivered by a micro-catheter with a small outside diameter giving easier access to the most distant aneurysms without the addition of any supplementary material. Placement time is thus shortened. Finally, radio-opaque markers (wires and/or rings) enable real time display of the correct position of the device. - Several methods of fabrication of the
device 1 are described below. - According to a first method of fabricating the device illustrated in
FIGS. 6a, 6b, 6c and 6d , the method includes afirst step 61 in which a first stent 65 with a first mesh size is inserted partly in a second stent 66 with a second mesh finer than the first mesh, so as to form a portion 67 with a large mesh with the same mesh size as the first stent 65 and a portion 68 with a fine mesh, the mesh size of which is the superposition of the first and the second stent 65, 66. In asecond step 62, anode 14 is formed in the portion 68 with a fine mesh. Thenode 14 is positioned such that there is afine zone node 14 is a separation between theintermediate portion 4 and thehead 5. In athird step 63, the second stent 68 that is located on theintermediate portion 4 and that with the first stent 67 forms thefine zone 69, is retracted along the direction of the arrows A″ towards thehead 5 so as not to leave anything in theintermediate portion 4 other than the first stent 65. Thus, the mesh of the intermediate portion is the same as the mesh of the first stent 65. The mesh of thehead 5 comprises three layers, namely a first layer of the first stent 65, a second layer of the second stent 66 and a third layer of the second stent 66 that corresponds to the retracted portion in thethird step 63. In afourth step 64, a forming rod B″ comprising an ellipsoid shaped end to form theintermediate portion 4 is inserted in the first stent 65 until it stops onnode 14 and a forming element C for which the curve is a corresponding impression of a dome and is inserted in the second stent 68 stopping in contact onnode 14. All these elements are inserted in a mould D for which the moulding cavity defines a tubular portion and an ellipsoid portion and a dome-shaped portion. In a fifth step, the mould is heated so as to heat seal the final device. - According to a second method of fabricating the device illustrated in
FIGS. 7a, 7b and 7c , the device comprises a first step in which a first rod B′ comprising an ellipsoid-shaped end is inserted in astent 74. Thestent 74 comprises alarge mesh part 75 and asmall mesh part 75. The first rod B′ is inserted until the end is adjacent to thesmall mesh portion 75. In a second step 73, a dome-shaped forming element is inserted in thefine mesh part 75 of the stent. In this step, thestent 74 and the elements A′, C′ are inserted in a mould D′. The assembly is then heated in the mould D′ to heat seal the final device. Thenode 14 is fabricated in mould D′ by heat sealing and due to the particular shape of the mould that enables local narrowing of the diameter of the device. - The dome may have a complex geometry, to optimise diversion of the blood flow
FIG. 8 illustrates a geometry of the dome capable of interrupting the blood flow. The density of the mesh of the head in the form of a flower is advantageously capable of efficiently diverting the blood flow. The flower shape is obtained by retracting theportion 69 several times inside thehead 5. - In order to satisfy an industrial need, the moulds used for the first and second methods can be in the form of a handle of variable section in which several devices can be fabricated simultaneously.
- Naturally a person competent in the field of the invention can make modifications to the description given above, to satisfy special needs.
Claims (14)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1750227A FR3061647B1 (en) | 2017-01-11 | 2017-01-11 | INTRA-ANEVRISMAL DEVICE |
FR1750227 | 2017-01-11 | ||
PCT/EP2018/050698 WO2018130624A1 (en) | 2017-01-11 | 2018-01-11 | Intra-aneurysm device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190343533A1 true US20190343533A1 (en) | 2019-11-14 |
Family
ID=58347671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/477,173 Pending US20190343533A1 (en) | 2017-01-11 | 2018-01-11 | Intra-aneurysmal device |
Country Status (5)
Country | Link |
---|---|
US (1) | US20190343533A1 (en) |
EP (1) | EP3568088B1 (en) |
ES (1) | ES2881643T3 (en) |
FR (1) | FR3061647B1 (en) |
WO (1) | WO2018130624A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10888414B2 (en) | 2019-03-20 | 2021-01-12 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
WO2021183793A3 (en) * | 2020-03-11 | 2021-10-21 | Microvention, Inc. | Devices for treatment of vascular defects |
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US11648013B2 (en) | 2016-03-11 | 2023-05-16 | Cerus Endovascular Limited | Occlusion device |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US12070220B2 (en) | 2020-03-11 | 2024-08-27 | Microvention, Inc. | Devices having multiple permeable shells for treatment of vascular defects |
US12082821B2 (en) | 2008-05-02 | 2024-09-10 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US12082819B2 (en) | 2019-03-15 | 2024-09-10 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US12096940B2 (en) | 2013-08-16 | 2024-09-24 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3771437A1 (en) * | 2019-07-29 | 2021-02-03 | Université de Montpellier | Intra-aneurysm device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090143786A1 (en) * | 2007-12-03 | 2009-06-04 | Boston Scientific Scimed, Inc. | Implantable device with electrolytically detachable junction having multiple fine wires and method of introduction |
US20120172927A1 (en) * | 2010-11-12 | 2012-07-05 | Campbell Benjamin D | Left atrial appendage occlusive devices |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1804719A2 (en) | 2004-09-22 | 2007-07-11 | Lee R. Guterman | Cranial aneurysm treatment arrangement |
US20110022149A1 (en) * | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
AU2009274126A1 (en) * | 2008-07-22 | 2010-01-28 | Covidien Lp | Vascular remodeling device |
WO2012158883A1 (en) * | 2011-05-19 | 2012-11-22 | Tyco Healthcare Group Lp | Vascular remodeling device |
-
2017
- 2017-01-11 FR FR1750227A patent/FR3061647B1/en active Active
-
2018
- 2018-01-11 ES ES18700881T patent/ES2881643T3/en active Active
- 2018-01-11 EP EP18700881.8A patent/EP3568088B1/en active Active
- 2018-01-11 WO PCT/EP2018/050698 patent/WO2018130624A1/en unknown
- 2018-01-11 US US16/477,173 patent/US20190343533A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090143786A1 (en) * | 2007-12-03 | 2009-06-04 | Boston Scientific Scimed, Inc. | Implantable device with electrolytically detachable junction having multiple fine wires and method of introduction |
US20120172927A1 (en) * | 2010-11-12 | 2012-07-05 | Campbell Benjamin D | Left atrial appendage occlusive devices |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12082821B2 (en) | 2008-05-02 | 2024-09-10 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US12096940B2 (en) | 2013-08-16 | 2024-09-24 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US12029431B2 (en) | 2014-04-30 | 2024-07-09 | Stryker Ireland Technology, Ltd. | Occlusion device |
US11389174B2 (en) | 2014-04-30 | 2022-07-19 | Cerus Endovascular Limited | Occlusion device |
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US12076022B2 (en) | 2015-12-07 | 2024-09-03 | Stryker Ireland Technology Ltd. | Occlusion device |
US11648013B2 (en) | 2016-03-11 | 2023-05-16 | Cerus Endovascular Limited | Occlusion device |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US12082819B2 (en) | 2019-03-15 | 2024-09-10 | Microvention, Inc. | Filamentary devices for treatment of vascular defects |
US10888414B2 (en) | 2019-03-20 | 2021-01-12 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US12023034B2 (en) * | 2020-03-11 | 2024-07-02 | Microvention, Inc. | Devices for treatment of vascular defects |
US12070220B2 (en) | 2020-03-11 | 2024-08-27 | Microvention, Inc. | Devices having multiple permeable shells for treatment of vascular defects |
WO2021183793A3 (en) * | 2020-03-11 | 2021-10-21 | Microvention, Inc. | Devices for treatment of vascular defects |
Also Published As
Publication number | Publication date |
---|---|
FR3061647B1 (en) | 2020-06-19 |
WO2018130624A1 (en) | 2018-07-19 |
ES2881643T3 (en) | 2021-11-30 |
EP3568088B1 (en) | 2021-04-28 |
FR3061647A1 (en) | 2018-07-13 |
EP3568088A1 (en) | 2019-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190343533A1 (en) | Intra-aneurysmal device | |
US11166731B2 (en) | Systems and methods for treating aneurysms | |
EP3672499B1 (en) | Occlusion device | |
EP3600068B1 (en) | Devices for embolization of body structures | |
US9107670B2 (en) | Implant, especially for the occlusion of bifurcation aneurysms | |
EP1750619B1 (en) | Flexible vascular occluding device | |
AU2016374360B2 (en) | Implant | |
EP3162322B1 (en) | Fork-type covered stent | |
KR101480514B1 (en) | Stent for cerebral aneurysm coil embolization | |
US20150250628A1 (en) | Implant | |
US11179160B2 (en) | Implant having a detachable mechanism | |
EP2596754A1 (en) | Medical implant and manufacturing method thereof | |
CN113069168B (en) | Aneurysm plugging device | |
CN109745094B (en) | Plugging device | |
US20190298387A1 (en) | Aneurysm treatment coils | |
CN215018304U (en) | Aneurysm occlusion device | |
JP2018537182A (en) | Band-shaped closure means | |
CN110662513B (en) | Delivery system for deploying self-expanding tubes and method of deploying self-expanding tubes | |
US20230355243A1 (en) | Systems and methods for treating aneurysms | |
CN118139588A (en) | Device for treating vascular defects | |
JP2024538262A (en) | Vascular disorder treatment device | |
JP6055163B2 (en) | Stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: SATT AXLR, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COSTALAT, VINCENT;REEL/FRAME:064754/0428 Effective date: 20230816 Owner name: UNIVERSITE DE MONTPELLIER, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COSTALAT, VINCENT;REEL/FRAME:064754/0428 Effective date: 20230816 Owner name: CENTRE HOSPITALIER ET UNIVERSITAIRE DE MONTPELLIER, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COSTALAT, VINCENT;REEL/FRAME:064754/0428 Effective date: 20230816 |
|
STCC | Information on status: application revival |
Free format text: WITHDRAWN ABANDONMENT, AWAITING EXAMINER ACTION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |